EC
FPRX
EcoR1 Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-379,945
| Closed | -$1.79M | – | 76 |
|
|
2020
Q3 | $1.79M | Hold |
379,945
| – | – | 0.13% | 37 |
|
|
2020
Q2 | $2.32M | Buy |
379,945
+123,870
| +48% | +$756K | 0.17% | 39 |
|
|
2020
Q1 | $581K | Buy |
+256,075
| New | +$581K | 0.06% | 49 |
|
|
2019
Q1 | – | Sell |
-326,775
| Closed | -$3.04M | – | 51 |
|
|
2018
Q4 | $3.04M | Buy |
+326,775
| New | +$3.04M | 0.3% | 36 |
|
|
2018
Q2 | – | Sell |
-1,240,470
| Closed | -$21.3M | – | 41 |
|
|
2018
Q1 | $21.3M | Buy |
+1,240,470
| New | +$21.3M | 2.14% | 12 |
|
|
2017
Q1 | – | Sell |
-298,712
| Closed | -$15M | – | 40 |
|
|
2016
Q4 | $15M | Buy |
298,712
+12,100
| +4% | +$606K | 4.77% | 9 |
|
|
2016
Q3 | $15M | Buy |
+286,612
| New | +$15M | 4.62% | 7 |
|
|
2016
Q2 | – | Sell |
-500,757
| Closed | -$20.3M | – | 35 |
|
|
2016
Q1 | $20.3M | Sell |
500,757
-218,243
| -30% | -$8.87M | 7.11% | 2 |
|
|
2015
Q4 | $29.8M | Buy |
719,000
+570,000
| +383% | +$23.7M | 9.37% | 2 |
|
|
2015
Q3 | $2.29M | Buy |
+149,000
| New | +$2.29M | 1.04% | 18 |
|